AERIE PHARMACEUTICALS INC - NOTE 1.500%10/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q4 2022

Type / Class
Debt / NOTE 1.500%10/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AERIE PHARMACEUTICALS INC - NOTE 1.500%10/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2022 Q4 $0 $0 -$301,724,229 0
2022 Q3 $307,596,000 $301,724,240 +$14,529,569 98.4% 19
2022 Q2 $294,931,390 $252,622,640 -$11,635,374 85.33% 19
2022 Q1 $307,567,000 $277,902,810 +$3,905,198 90.5% 19
2021 Q4 $297,436,799 $252,929,139 +$15,721,681 84.0% 22
2021 Q3 $279,847,579 $257,727,293 -$6,240,890 90.9% 23
2021 Q2 $282,472,669 $286,465,655 -$11,752,250 99.59% 22
2021 Q1 $293,767,612 $308,631,318 +$2,926,496 103.78% 23
2020 Q4 $310,337,630 $288,642,967 +$19,044,868 91.9% 22
2020 Q3 $314,112,868 $260,461,734 +$257,240,914 80.71% 24